Table 6.

Multivariable Analyses of Adherence to SGA Monitoring Guidelines (“Routinely” Monitored^a), Part 1

	Patient history		Height and weight		Blood pressure
	OR (99% CI)	p value	OR (99% CI)	p value	OR (99% CI)	p value
Psychiatrist characteristics
Male			0.32 (0.07, 1.39)	0.05	0.47 (0.21, 1.08)	0.02
White, non-Hispanic
Board certified in child and adolescent psychiatry
Years in practice
Psychiatrist attitudes and use of SGAs
Off-label SGA use	0.57 (0.29, 1.13)	0.04	0.33 (0.09, 1.24)	0.03
Feel the risk of metabolic syndrome is low enough to warrant the use of SGAs					0.36 (0.16, 0.81)	0.001
Are comfortable performing a physical examination on patients					2.61 (1.04, 6.54)	0.007
Feel patients are noncompliant with blood work.
Practice characteristics
Practice settingb
Private	0.88 (0.40, 1.97)	0.69	0.58 (0.06, 5.50)	0.53	0.32 (0.10, 1.01)	0.01
Community mental health center	0.88 (0.36, 2.12)	0.70	0.87 (0.07, 10.49)	0.88	0.35 (0.10, 1.23)	0.03
More than 50% of patients have private insurance
Electronic health records			4.48 (0.54, 37.46)	0.07	2.15 (0.85, 5.43)	0.03
Can measure vital signs, height, and weight on site			7.89 (1.89, 32.97)	<0.001
Can get blood drawn on site
Visits per week
Population densityc
Suburban
Rural

Bolding indicates p<0.01.

^aRoutinely indicates 1–3x/year or every visit.

^bReference is inpatient/outpatient facility.

^cReference is urban.

SGA, second generation antipsychotic.